4/25
09:07 am
nvs
20 Countries with the Highest Rates of Stomach Cancer in the World [Yahoo! Finance]
Low
Report
20 Countries with the Highest Rates of Stomach Cancer in the World [Yahoo! Finance]
4/24
11:33 am
nvs
Novartis AG (NYSE: NVS) had its price target raised by analysts at BMO Capital Markets from $114.00 to $116.00. They now have a "market perform" rating on the stock.
Low
Report
Novartis AG (NYSE: NVS) had its price target raised by analysts at BMO Capital Markets from $114.00 to $116.00. They now have a "market perform" rating on the stock.
4/24
01:35 am
nvs
Roche Sales Decline in Last Quarter of Pandemic Impact [BNN Bloomberg (Canada)]
Low
Report
Roche Sales Decline in Last Quarter of Pandemic Impact [BNN Bloomberg (Canada)]
4/24
12:33 am
nvs
Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria [Yahoo! Finance]
Low
Report
Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria [Yahoo! Finance]
4/23
06:30 pm
nvs
Why Novartis Stock Topped the Market on Tuesday [Yahoo! Finance]
Low
Report
Why Novartis Stock Topped the Market on Tuesday [Yahoo! Finance]
4/23
05:20 pm
nvs
FDA Approves Novartis' Lutathera As First Therapy For Pediatric Patients With Gastroenteropancreatic Neuroendocrine Tumors [Yahoo! Finance]
Low
Report
FDA Approves Novartis' Lutathera As First Therapy For Pediatric Patients With Gastroenteropancreatic Neuroendocrine Tumors [Yahoo! Finance]
4/23
01:48 pm
nvs
Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors [Yahoo! Finance]
Low
Report
Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors [Yahoo! Finance]
4/23
01:40 pm
nvs
Novartis accused of promoting asthma drug for preterm labor despite brain risk [Reuters]
Low
Report
Novartis accused of promoting asthma drug for preterm labor despite brain risk [Reuters]
4/23
11:31 am
nvs
Novartis Ag (NVS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Novartis Ag (NVS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
4/23
11:08 am
nvs
Compared to Estimates, Novartis (NVS) Q1 Earnings: A Look at Key Metrics [Yahoo! Finance]
Low
Report
Compared to Estimates, Novartis (NVS) Q1 Earnings: A Look at Key Metrics [Yahoo! Finance]
4/23
10:25 am
nvs
Drugmaker Novartis climbs after guidance rise on sales of blockbuster drugs [MSNBC.com]
Low
Report
Drugmaker Novartis climbs after guidance rise on sales of blockbuster drugs [MSNBC.com]
4/23
08:58 am
nvs
Pharma giant Novartis sees shares jump after strong Q1 [Yahoo! Finance]
Low
Report
Pharma giant Novartis sees shares jump after strong Q1 [Yahoo! Finance]
4/23
04:25 am
nvs
Drugmaker Novartis climbs 4.4% after guidance rise on sales of blockbuster drugs [MSNBC.com]
Low
Report
Drugmaker Novartis climbs 4.4% after guidance rise on sales of blockbuster drugs [MSNBC.com]
4/23
02:07 am
nvs
Novartis lifts guidance after first-quarter results beat expectations [CNBC]
Low
Report
Novartis lifts guidance after first-quarter results beat expectations [CNBC]
4/23
01:54 am
nvs
UPDATE 2-Novartis lifts guidance after Q1 results beat expectations [Yahoo! Finance]
Low
Report
UPDATE 2-Novartis lifts guidance after Q1 results beat expectations [Yahoo! Finance]
4/23
01:42 am
nvs
Novartis Raises Forecast as Sales of New Blockbusters Climb [BNN Bloomberg (Canada)]
Low
Report
Novartis Raises Forecast as Sales of New Blockbusters Climb [BNN Bloomberg (Canada)]
4/23
01:20 am
nvs
Novartis delivers double-digit sales growth and core margin expansion in Q1; FY 2024 guidance raised [Yahoo! Finance]
Low
Report
Novartis delivers double-digit sales growth and core margin expansion in Q1; FY 2024 guidance raised [Yahoo! Finance]
4/22
02:53 pm
nvs
Top Analyst Reports for Novartis, American Express & ConocoPhillips [Yahoo! Finance]
Low
Report
Top Analyst Reports for Novartis, American Express & ConocoPhillips [Yahoo! Finance]
4/22
01:15 am
nvs
Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening immunology offering [Financial Post (Toronto, Ontario, Canada)]
Low
Report
Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening immunology offering [Financial Post (Toronto, Ontario, Canada)]
4/22
01:12 am
nvs
Samsung Bioepis Gains European Commission Approval For PYZCHIVA™, a Biosimilar to Stelara (Ustekinumab) [Yahoo! Finance]
Low
Report
Samsung Bioepis Gains European Commission Approval For PYZCHIVA™, a Biosimilar to Stelara (Ustekinumab) [Yahoo! Finance]
4/22
01:09 am
nvs
Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening immunology offering [Yahoo! Finance]
Low
Report
Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening immunology offering [Yahoo! Finance]
4/21
08:15 am
nvs
Breast Cancer Therapeutics Market To Reach USD 53.2 Billion By 2032, Says DataHorizzon Research [Yahoo! Finance]
Low
Report
Breast Cancer Therapeutics Market To Reach USD 53.2 Billion By 2032, Says DataHorizzon Research [Yahoo! Finance]
4/19
12:14 pm
nvs
Novartis (NVS) to Report Q1 Earnings: What to Expect? [Yahoo! Finance]
Low
Report
Novartis (NVS) to Report Q1 Earnings: What to Expect? [Yahoo! Finance]
4/19
08:00 am
nvs
The Bicycle Day Dream Bike: A Carbon Fiber Hommage To Albert Hofmann [Forbes]
Low
Report
The Bicycle Day Dream Bike: A Carbon Fiber Hommage To Albert Hofmann [Forbes]
4/19
04:13 am
nvs
Amarna Therapeutics announces appointment of Aurelia Caparrós as new Chief Business Officer [Yahoo! Finance]
Low
Report
Amarna Therapeutics announces appointment of Aurelia Caparrós as new Chief Business Officer [Yahoo! Finance]